Slater & Gordon announce record 2013 result

Legal firm no longer backpacking in the UK.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Slater & Gordon (ASX: SGH) has announced record results for the 2013 year. Highlights include:

  • Revenue up 36.7% to $297.6 million
  • Net profit up 67.6% to $41.9 million
  • Cash flow is sound at $32.7 million
  • Debt management is good with interest cover of 11
  • Earnings per share 23.8c, dividend 6.6c fully franked

Professional service firms such as lawyers can at times be very attractive investments. With high barriers to entry, limited competition and a fairly litigious society, above GDP growth can be reasonably assured – even more so if you're good at what you're doing, and Slater & Gordon fits neatly into this mould.

Its record of progress is interesting:

  • First law firm in the world to list on a stock exchange (2007)
  • 75% of revenue derived from personal injury litigation
  • Net profit margin hovers around 15%
  • 95% success rate with cases undertaken on a no win, no fee basis
  • Successful expansion into the UK, a market 4-5 times the size of Australia
  • Taking steps to expand range of legal services, smoothing out cashflow

It's estimated Slater & Gordon has a dominant 25% of the personal injury (PI) market in Australia and the domestic expansion into family law, estate law, and other consumer legal services is expected to provide low double digit growth (albeit off a low base).

Slater & Gordon is also involved in class actions, now largely funded by outside parties. Although its record in this specialty is patchier than that of IMF (ASX: IMF) it does provide another string to its bow. 2013 results were again negatively affected by the Vioxx class action going against it although the major write down here was recorded in the 2012 results.

The most promising area for future growth is the bulking up of the UK presence. In the UK, law practices are extremely fragmented and opportunities for consolidation and branding are open. Practice areas in the UK firms are similar to Slater & Gordon's operations in Australia.

In the UK personal injury cases are sourced by claim management companies which then on sell 'leads' to legal firms. Slater & Gordon has sidestepped this crusty convention by marketing its own "Claims Direct" business, now one of the most recognised legal brand names in Britain.

Slater & Gordon has announced the acquisition of two more UK legal firms (effective this month), and an agreement signed with a third to be finalised in early 2014. The new acquisitions are expected to be earnings per share accretive in 2014 allowing for dilution. Revenue from the UK is forecast to be more than $115 million in 2014 and SGH has now established a credible platform for substantial organic growth in Britain.

Foolish takeaway

Although no industry is recession-proof, legal services come pretty close to it. There are some regulatory risks (for example, Slater & Gordon is unable to advertise in some states), however, these seem to be manageable. At $3.20 Slater & Gordon's 2014 price earnings ratio sits at 11.8 – undemanding for a company with a very solid growth outlook. Slater & Gordon is not for income investors, as profit is retained in order to grow the business. In this Fool's opinion, this business is a good buy.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Peter Andersen owns shares in Slater & Gordon and IMF.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »